+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

RNA recombination of murine coronaviruses: recombination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus 2



RNA recombination of murine coronaviruses: recombination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus 2



Journal of Virology 62(6): 1989-1998



It has previously been shown that the murine coronavirus mouse hepatitis virus (MHV) undergoes RNA recombination at a relatively high frequency in both tissue culture and infected animals. Thus far, all of the recombination sites had been localized at the 5' half of the RNA genome. We have now performed a cross between MHV-2, a fusion-negative murine coronavirus, and a temperature-sensitive mutant of the A59 strain of MHV, which is fusion positive at the permissive temperature. By selecting fusion-positive viruses at the nonpermissive temperature, we isolated several recombinants containing multiple crossovers in a single genome. Some of the recombinants became fusion negative during the plaque purification. The fusion ability of the recombinants parallels the presence or absence of the A59 genomic sequences encoding peplomers. Several of the recombinants have crossovers within 3' end genes which encode viral structural proteins, N and E1. These recombination sites were not specifically selected with the selection markers used. This finding, together with results of previous recombination studies, indicates that RNA recombination can occur almost anywhere from the 5' end to the 3' end along the entire genome. The data also show that the replacement of A59 genetic sequences at the 5' end of gene C, which encodes the peplomer protein, with the fusion-negative MHV-2 sequences do not affect the fusion ability of the recombinant viruses. Thus, the crucial determinant for the fusion-inducing capability appears to reside in the more carboxyl portion of the peplomer protein.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 041155796

Download citation: RISBibTeXText

PMID: 2835504


Related references

Sequence of mouse hepatitis virus A59 mRNA 2: indications for RNA recombination between coronaviruses and influenza C virus. Virology 166(2): 415-422, 1988

High recombination and mutation rates in mouse hepatitis virus suggest that coronaviruses may be potentially important emerging viruses. Advances in Experimental Medicine and Biology 380: 571-576, 1995

Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism. Journal of Virology 72(12): 9628-9636, 1998

Nature of mouse hepatitis virus RNA recombination between defective interfering particle and helper virus. Experientia 52(ABSTR ): A48, 1996

Structural basis for coronavirus-mediated membrane fusion. Crystal structure of mouse hepatitis virus spike protein fusion core. Journal of Biological Chemistry 279(29): 30514-30522, 2004

Crystallization and preliminary crystallographic analysis of the fusion core of the spike protein of the murine coronavirus mouse hepatitis virus (MHV). Acta Crystallographica. Section D, Biological Crystallography 60(Pt 11): 2013-2015, 2004

Purified, soluble recombinant mouse hepatitis virus receptor, Bgp1(b), and Bgp2 murine coronavirus receptors differ in mouse hepatitis virus binding and neutralizing activities. Journal of Virology 72(9): 7237-7244, 1998

Mouse fibroblast mutants selected for survival against mouse hepatitis virus infection show increased resistance to infection and virus-induced cell fusion. Advances in Experimental Medicine and Biology 276: 59-66, 1990

Induction of lytic plaques by murine leukemia virus in murine sarcoma virus-transformed nonproducer mouse cells persistently infected with mouse hepatitis virus MHV-S. Intervirology 11(2): 69-73, 1979

Mutagenesis of the genome of mouse hepatitis virus by targeted RNA recombination. Advances in Experimental Medicine and Biology 380: 543-549, 1995

Complementation, recombination, and reversion experiments using mouse hepatitis virus mutants. AAAS Annual Meeting & Science Innovation Exposition 165: A 92, 21-26 January, 1999

Site-directed mutagenesis of the genome of mouse hepatitis virus by targeted RNA recombination. Advances in Experimental Medicine and Biology 342: 143-148, 1993

Effect of exogenous mouse interferon on murine fulminant hepatitis induced by mouse hepatitis virus type 2. Digestive Diseases & Sciences 31(2): 177-180, 1986

Prevalence and clinical associations of previous and occult hepatitis B virus infection in hepatitis C virus positive and hepatitis B virus surface antigen negative patients with chronic liver disease. Hepatology 34(4 Pt 2): 562A, 2001

Effect of exogenous mouse interferon on murine fulminant hepatitis induced by mouse hepatitis virus mhv 2. Gastroenterologia Japonica 19(4): 386-387, 1984